Spermatech is a biopharmaceutical company focusing on the development of highly specific non-hormonal, small molecule male contraceptives. Spermatech's technologies are based on the discovery of a gene/protein that is crucial for sperm motility. The company has developed proprietary technology and has the patent rights to this gene/protein and its use in manipulating sperm motility in human. Spermatech is looking for strategic partners, alliances, joint ventures and investors interested in the described project. The company is also looking at outsourcing as an option. At the present time Spermatech is particularly interested in partners and/or service companies with the capability for high throughput screening or specialized screening.
| Website | http://www.spermatech.com |
| Revenue | $4 million |
| Employees | View employees |
| Address | Gaustadalléen 21, Oslo, Oslo 0349, NO |
| Phone | +47 22 13 79 11 |
| Industry | Biotechnology, Pharmaceuticals, Healthcare |
| Competitors | Genomic Health, REPROTECH®, Embryotech Laboratories Inc., AlphaBio, Inc., Eureka Biotechnology Co., Limited, Celltech Labs Inc., Arcadian Services of Colorado, Biomax Health Products Inc, Conception Technologies, Inc., BioAgility +1 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular SpermaTech AS employee's phone or email?
SpermaTech AS Questions
The SpermaTech AS annual revenue was $4 million in 2026.
SpermaTech AS is based in Oslo, Oslo.
The NAICS codes for SpermaTech AS are [5417, 541713, 541, 54, 54171].
The SIC codes for SpermaTech AS are [873, 87].
